Nexalin Technology, Inc. (NXL) fundamentals score
Nexalin is headquartered, and maintains its base of management and operations, in Houston, Texas. Nexalin Technology designs and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic.
Electromedical & Electrotherapeutic Apparatus · Healthcare · Listed on NASDAQ
Overall: 3.8 out of 10, Weak long-term fundamentals
- Growth: 3.5/10
- Profitability: 3.4/10
- Financial health: 4.1/10
- Earnings quality: 6.9/10
- Valuation: 1.3/10
Scores are calculated from Nexalin Technology, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10